Metraipolis › archive › dc_e7712e015442

Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study — Europe PMC PMID:42298273

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42298273
DOI
10.1007/s10384-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-19T09:44:59.023Z
SHA-256 of the archived text
41e8491070a47e8514b3d4c43228307c2ae7afc7d26d34b171885acc00dcca9a
Stable URL of this page
https://metraipolis.com/documento/dc_e7712e015442

How to cite

Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study — Europe PMC PMID:42298273 — Europe PMC (en), https://europepmc.org/article/MED/42298273 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e7712e015442 (Metraipolis archive dc_e7712e015442, sha256 41e8491070a47e8514b3d4c43228307c2ae7afc7d26d34b171885acc00dcca9a)
BibTeX
@misc{dce7712e015442,
  title = {Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study — Europe PMC PMID:42298273},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42298273},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e7712e015442; sha256 41e8491070a47e8514b3d4c43228307c2ae7afc7d26d34b171885acc00dcca9a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42298273. Agents can read the archived copy with the MCP tool read_document.